Adjustable Gravitational vs. Adjustable Differential Pressure Valves in iNPH

  • STATUS
    Recruiting
  • End date
    Jan 1, 2023
  • participants needed
    40
  • sponsor
    Military University Hospital, Prague
Updated on 25 January 2021
Investigator
Ondřej Bradáč, M.D, M.Sc., Ph.D
Primary Contact
Neurosurgical department of the Central Military Hospital, 1st Faculty of Medicine of Charles University (1.2 mi away) Contact

Summary

The goal of the study is to verify theoretical benefit of ventriculoperitoneal shunting with MIETHKE M.blue valve in patients with iNPH. The study is designed to assess walking and balance, urinary function, cognitive performance and quality of life before and after shunting and compare the results between the patients with MIETHKE M.blue and MIETHKE proGAV 2.0 (with SA 2.0) valves.

Description

Patients who will be referred to Military University Hospital Prague with suspicion of normal pressure hydrocephalus will be tested by conventional methods to consider implantation of a ventriculo-peritoneal shunt. This testing is performed during hospitalization and includes clinical examination of the patient by a neurosurgeon, neurologist and neuropsychologist including neuropsychological questionnaires or tests - MoCA, AVLT, ROCFT, TMT A + B, Phonemic Verbal Fluency Test (N, K, P), Semantic Fluence Test (animals, vegetables), subtest of battery WAIS III and GDS. Clinical examinations are followed by magnetic resonance imaging. Functional testing of cerebrospinal fluid circulation is initiated on the second day unless another cause of the patient's symptoms (AD, Parkinson's disease, vascular dementia, tumor, obstructive type of hydrocephalus - eg aqueductal stenosis, Blake's pouch cyst etc.) is present. The functional testing will involve lumbar infusion test and subsequent external lumbar drainage (ELD) for 120h, including biochemical analysis of CSF during the ELD. After this time, the objective improvement of the patient's gait with the aid of the Dutch Gait Scale will be evaluated with respect to the subjective evaluation by the patient or family (changes in urinary incontinence / urgency, headaches, etc.). If the diagnosis of normotensive hydrocephalus is confirmed, the patient will be indicated for a VP shunt implantation, which is used for permanent derivation of cerebrospinal fluid into the peritoneal cavity. As a result of cerebrospinal fluid derivation, the clinical condition of most of the patients improves. The operation process described by Michael J. Fritsch (Fritsch et al. 2014) will be modified for various valve types in accordance with the manufacturer's recommendations and assumed conditions for proper valve adjustment. Patients will be randomly implanted with a M.blue or proGAV 2.0 (with SA 2.0) valve (Christoph Miethke GmbH & Co. KG) in a randomized manner to form two study groups. The efficacy and safety of the proGAV 2.0 (with SA 2.0) valve has already been confirmed in a randomized prospective study in patients with idiopathic normotensive hydrocephalus (Lemcke et al. 2013). The theoretical benefit of the M.blue valve lies in the targeted modification of the cerebrospinal fluid diversion during the active time of a day, when the opening pressure of the valve's gravitational unit is controlled according to the angle between the valve and the horizontal line. The basal opening pressure of the valve that has to be overcome in the supine position is controlled with a fixed differential pressure unit. ProGAV 2.0 is an adjustable differential pressure valve implanted with a shunt-assistant SA 2.0. The shunt-assistant represents a fixed gravity unit that increases the pressure in the standing position, which must be overcome for the cerebrospinal fluid flow through th shunt. The opening pressure of the valve could be selected according to the patient's height and sex. The basal opening pressure of the valve that must be overcome in the supine position is controlled with an adjustable differential pressure unit that can be adjusted before and after the shunt implantation. In both valves, the opening pressure is the sum of the opening pressures of the gravitational and differential pressure units. The theoretical benefit of the M.blue valve is the possibility of changing the opening pressure of the gravitational unit regulated according to the position of the head in the space and thus aiming more at the pressure conditions when the valve is not parallel to the horizontal line.

Patients will not be familiar with the type of valve implanted with respect to subjective evaluation of patients during the follow-up. Initial valve settings will be in accordance with the manufacturer's recommendations. Follow-up of the patients will be guided in the usual regime according to the natural history of the disease: at one month of follow-up an outpatient clinical examination by a neurosurgeon, including brain CT scan; at three-months of follow-up an evaluation during a two-day hospitalization including collection of the following questionnaires, brain MRI, clinical examination by a neurosurgeon, neurologist and neuropsychologist and collection of cerebrospinal fluid from the pre-chamber for the biochemical analysis; at six-months an outpatient examination by a neurosurgeon; at one year of follow-up an evaluation during a two-day hospitalization including collection of the following questionnaires, brain MRI, clinical examination by a neurosurgeon, neurologist and neuropsychologist and collection of cerebrospinal fluid from the pre-chamber valve for biochemical analysis; at two-years of follow-up an outpatient clinical examination by neurosurgeon and neuropsychologist including brain CT scan including collection of the following questionnaires and collection of the cerebrospinal fluid from the pre-chamber of the valve for biochemical analysis.

For the purpose of the study, the Dutch Gait scale (gait), UI-SF (incontinence) and MoCA (dementia) will be used to assess the outcome of the shunt operation to monitor the severity and nature of the main symptoms during the follow-up in pre-implant, three months, one year and after two years. The SF-12V2 will be used in a similar mode to monitor the quality of life of the patients. Severity of the symptoms will also be assessed by the Kiefer Scale, which was developed directly to monitor patients with idiopathic normotensive hydrocephalus. Charlson comorbidity index will be used to monitor covariates. All clinical examinations by a neurosurgeon will monitor early and late complications of the short-circuit operation (infection, hemorrhage, overdrainage, underdrainage, shunt malfunction), the number of valve setting changes and their range, unscheduled checks and shunt revisions and other unexpected events.

The expected number of patients who will undergo all examinations after an annual check is 40 (20 and 20).

The expected benefit of the study is in particular to confirm the theoretical assumptions of an adjustable gravitational valve in patients with idiopathic normal pressure hydrocephalus and thus in improvement of the quality and life expectancy of these patients.

Details
Condition NORMAL PRESSURE HYDROCEPHALUS
Treatment MIETHKE M.blue®, MIETHKE proGAV 2.0® (with SA 2.0®)
Clinical Study IdentifierNCT04434053
SponsorMilitary University Hospital, Prague
Last Modified on25 January 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Age of patients (between 60 and 85 years old)
Clinically suspected Normal Pressure Hydrocephalus (NPH) with at least gait and one other symptom from Hakim-Adams triad (incontinence or dementia)
maximal initial pressure of 20 cmH2O during lumbar infusion test
Rout during LIT >9mmHg/mlmin
at least 15% improvement in Gait scale score after ELD
Conclusion of neuropsychological examination suggestive of iNPH (based on MoCA, Test of phonemic and verbal fluency, RAVLT, ROCFT, TMT A and B, Subtest of WAIS III, GDS)

Exclusion Criteria

Aetiology of hydrocephalus other than idiopathic normal pressure hydrocephalus (secondary normal pressure hydrocephalus - history of meningitis or subarachnoid haemorrhage, obstructive type of hydrocephalus - eg aqueductal stenosis, Blake's pouch cyst)
Intracranial tumor
Other neurodegenerative diseases may be present (AD, Parkinson's disease, Lewy body dementia, Progressive supranuclear palsy and cerebrovascular diseases), however have to be mild and evaluated in neurological, neuropsychological examinations and on MRI
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note